Steven Cohen's DNA Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 76,908 shares of Ginkgo Bioworks Holdings, Inc. (DNA) worth $639,105, representing 0.00% of the portfolio. First purchased in 2024-Q4, this short-term holding has been held for 4 quarters.
Based on 13F filings, Steven Cohen has maintained this position in DNA for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 76,908 shares. Largest reduction occurred in Q2 2025, reducing 73,100 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Ginkgo Bioworks Holdings (DNA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Ginkgo Bioworks Holdings (DNA) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +76,908 | New Buy | 76,908 | $8.31 |
| Q2 2025 | -73,100 | Sold Out | 0 | $0.00 |
| Q1 2025 | -26,700 | Reduce 26.75% | 73,100 | $5.70 |
| Q4 2024 | +99,800 | New Buy | 99,800 | $9.82 |
Steven Cohen's Ginkgo Bioworks Holdings Investment FAQs
Steven Cohen first purchased Ginkgo Bioworks Holdings, Inc. (DNA) in Q4 2024, acquiring 99,800 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Ginkgo Bioworks Holdings, Inc. (DNA) for 4 quarters since Q4 2024.
Steven Cohen's largest addition to Ginkgo Bioworks Holdings, Inc. (DNA) was in Q4 2024, adding 99,800 shares worth $980,036.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 76,908 shares of Ginkgo Bioworks Holdings, Inc. (DNA), valued at approximately $639,105.
As of the Q4 2025 filing, Ginkgo Bioworks Holdings, Inc. (DNA) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Ginkgo Bioworks Holdings, Inc. (DNA) was 99,800 shares, as reported at the end of Q4 2024.